drugset / Trial / NCT01950039

Metabolic Effects of Betaine Supplementation

NCT01950039

RandomizedParallel-groupQuadruple-blindOther

Summary

Betaine is important in cellular metabolic pathways. Few epidemiologic studies link betaine levels to diabetes and cardiovascular disease. Small human studies suggest benefit for non-alcoholic liver disease. In this study we will determine if administration of betaine improves metabolic measures, liver fat and/or endothelial function in humans with glucose intolerance who are overweight.

Timeline

Start
2014-01
Primary completion
2017-12
Completion
2018-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Betaine Small molecule 4950 mg Oral